![Robert Waltermire](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Waltermire
Corporate Officer/Principal chez MADRIGAL PHARMACEUTICALS, INC.
Fortune : 1 M $ au 31/05/2024
Postes actifs de Robert Waltermire
Sociétés | Poste | Début | Fin |
---|---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/08/2021 | - |
Historique de carrière de Robert Waltermire
Anciens postes connus de Robert Waltermire
Sociétés | Poste | Début | Fin |
---|---|---|---|
Venatorx Pharmaceuticals, Inc.
![]() Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Corporate Officer/Principal | 01/01/1988 | 01/01/2020 |
Formation de Robert Waltermire
Franklin & Marshall College | Undergraduate Degree |
University of Maryland | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Venatorx Pharmaceuticals, Inc.
![]() Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Commercial Services |
- Bourse
- Insiders
- Robert Waltermire
- Expérience